HH
RPRX icon

Hilltop Holdings’s Royalty Pharma RPRX Stock Holding History

Hilltop Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
+3,850
New +$200K 0.02% 639
2026
Q1 		– Sell
-5,668
Closed -$219K – 863
2025
Q4 		$219K Sell
5,668
-145
-2% -$5.53K 0.01% 821
2025
Q3 		$205K Buy
+5,813
New +$210K 0.01% 870

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hilltop Holdings's RPRX Position: Q2 2026 in Review

Hilltop Holdings opened a new position in Royalty Pharma (RPRX) in Q2 2026: 3,850 shares worth $216K. The stake represents 0.02% of the portfolio and ranks #639 among its holdings. This is a return to the name: Hilltop Holdings previously reported a position in RPRX as recently as Q4 2025.

Hilltop Holdings first reported a position in RPRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $219K in Q4 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Hilltop Holdings held 3,850 shares of Royalty Pharma worth $216K as of Q2 2026.
  • Royalty Pharma was a new Hilltop Holdings position in Q2 2026.
  • Royalty Pharma made up 0.02% of Hilltop Holdings's portfolio in Q2 2026, its #639 holding.
  • Hilltop Holdings first reported a position in Royalty Pharma in Q3 2025 and has held it in 3 quarters since.
  • Hilltop Holdings's Royalty Pharma position peaked at $219K in Q4 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.